Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 유충규 | - |
dc.date.accessioned | 2016-08-27T02:08:32Z | - |
dc.date.available | 2016-08-27T02:08:32Z | - |
dc.date.issued | 2001 | - |
dc.identifier.issn | 0901-9928 | - |
dc.identifier.other | OAK-668 | - |
dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/215407 | - |
dc.description.abstract | The effects of 2-chloro-3-(4-hexylphenyl)-amino-1,4-napthoquinone (NQ304), an antithrombotic agent, on aggregation, binding of fibrinogen to glycoprotein IIb/IIIa and intracellular signals were investigated using human platelets. NQ303 inhibited thrombin-, arachidonic acid- and thapsigargin-induced aggregation of washed human platelets with the IC50 values of 22.2 +/- 0.7, 6.5 +/- 0.2, and 7.6 +/- 0.1 muM, respectively. NQ304 significantly inhibited fluorescein isothiocyanate-conjugated fibrinogen binding to human platelet surface glycoprotein IIb/IIa receptor by 75%, but failed to inhibit the fibrinogen binding to purified glycoprotein IIb/IIIa receptor. This result suggests that NQ304 inhibit platelet aggregation by suppression of an intracellular pathway that involves exposure of the glycoprotein IIb/IIIa receptor, rather than by direct inhibition of fibrinogen-glycoprotein IIb/IIa binding. NQ304 significantly inhibited thrombin-induced increase in intracellular Ca2+ mobilization at the dose of 30 muM and ATP secretion in a dose-dependent manner, it also inhibited thrombin- and arachidonic acid-induced thromboxane A? formation in human platelet dose-dependently. In conclusion, the antiplatelet mechanism of NQ304 may be due to the reduction of the thromboxane A(2) formation, inhibition of adenosine triphosphate release and intracellular calcium mobilization. | - |
dc.language | English | - |
dc.publisher | MUNKSGAARD INT PUBL LTD | - |
dc.title | Antiplatelet mechanism of 2-chloro-3-(4-hexylphenyl)amino-1,4-naphthoquinone (NQ304), an antithrombotic agent | - |
dc.type | Article | - |
dc.relation.issue | 4 | - |
dc.relation.volume | 88 | - |
dc.relation.index | SCIE | - |
dc.relation.startpage | 181 | - |
dc.relation.lastpage | 186 | - |
dc.relation.journaltitle | PHARMACOLOGY & TOXICOLOGY | - |
dc.identifier.doi | 10.1034/j.1600-0773.2001.d01-101.x | - |
dc.identifier.wosid | WOS:000168181300004 | - |
dc.author.google | Zhang, YH | - |
dc.author.google | Chung, KH | - |
dc.author.google | Ryu, CK | - |
dc.author.google | Lee, YH | - |
dc.author.google | Kim, TJ | - |
dc.author.google | Song, YS | - |
dc.author.google | Hwang, KA | - |
dc.author.google | Yun, YP | - |
dc.contributor.scopusid | 유충규(15846918400) | - |
dc.date.modifydate | 20180104081001 | - |